Cytokine-activated STAT3 homodimers and heterodimeric complexes, in combination with other transcription factors, govern the expression of target genes that oversee cell proliferation, inhibit programmed cell death, stimulate the growth of new blood vessels, facilitate immune evasion by cancers, and foster inflammation that supports tumor development. The gene discussed is STAT3; the disease is cancer.